Aripiprazol en el tratamiento de pacientes con discapacidad intelectual y elevación de los niveles de prolactina

  1. O.W. Muquebil Ali Al Shaban Rodríguez 1
  2. P. Pérez Castro 2
  1. 1 Servicio de Psiquiatría, Hospital Universitario San Agustín, Avilés, Asturias, España
  2. 2 Servicio de Endocrinología, Hospital Universitario Lucus Augusti, Lugo, España
Revista:
Semergen: revista española de medicina de familia

ISSN: 1138-3593

Ano de publicación: 2019

Número: 6

Páxinas: 430-431

Tipo: Artigo

DOI: 10.1016/J.SEMERG.2019.02.008 DIALNET GOOGLE SCHOLAR

Outras publicacións en: Semergen: revista española de medicina de familia

Referencias bibliográficas

  • E. González-Pablos, J.A. López-Villalobos, J.M. Valles-de la Calle, P. Paulino-Matos Elevación de prolactina en personas con discapacidad intelectual con tratamiento psicofarmacológico Semergen, 45 (2019), pp. e1-e8 Google Scholar
  • I. Besnard, V. Auclair, G. Callery, C. Gabriel-Bordenave, C. Roberge Antipsychotic-drug-induced hyperprolactinemia: Physiopathology, clinical features and guidance Encephale, 40 (2014), pp. 86-94 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • J.X. Chen, Y.A. Su, Q.T. Bian, L.H. Wei, R.Z. Zhang, Y.H. Liu, et al. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study Psychoneuroendocrinology, 58 (2015), pp. 130-140 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • A. Bacanli Aripiprazole use in children diagnosed with Down syndrome and comorbid autism spectrum disorders J Child Adolesc Psychopharmacol, 26 (2016), pp. 306-1308 CrossRefView Record in ScopusGoogle Scholar
  • A. Murru, C. Varo Causas y manejo de la hiperprolactinemia por antipsicóticos Psiquiatr Biol., 22 (2015), pp. 13-17 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • D. Mété, C. Dafreville, V. Paitel, P. Wind Aripiprazole, gambling disorder and compulsive sexuality Encephale., 42 (2016), pp. 281-283 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • P.M. Haddad, A. Wieck Antipsychotic-induced hyperprolactinaemia: Mechanisms, clinical features and management Drugs., 64 (2004), pp. 2291-2314 CrossRefView Record in ScopusGoogle Scholar
  • P.M. Haddad, A. Wieck Antipsychotic-induced hyperprolactinaemia: Mechanisms, clinical features and management Drugs., 64 (2004), pp. 2291-2314 CrossRefView Record in ScopusGoogle Scholar
  • M. Meng, W. Li, S. Zhang, H. Wang, J. Sheng, J. Wang, et al. Using aripiprazole to reduce antipsychotic-induced hyperprolactinemia: Meta-analysis of currently available randomized controlled trials Shanghai Arch Psychiatry., 27 (2015), pp. 4-17 View Record in ScopusGoogle Scholar
Fonte de datos: Dialnet